347 related articles for article (PubMed ID: 27429590)
21. [Expression of galectin-1 in carcinogenesis of oral mucosal epithelium].
Wei KJ; Pan HY; Yang X; Zhong LP; Ye DX; Zhang ZY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Sep; 46(9):524-7. PubMed ID: 22177353
[TBL] [Abstract][Full Text] [Related]
22. The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance.
Alam M; Kashyap T; Pramanik KK; Singh AK; Nagini S; Mishra R
Clin Oral Investig; 2017 Dec; 21(9):2721-2731. PubMed ID: 28233171
[TBL] [Abstract][Full Text] [Related]
23. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma.
Shang ZJ; Liu K; Liang DF
J Oral Pathol Med; 2009 Apr; 38(4):371-6. PubMed ID: 19141064
[TBL] [Abstract][Full Text] [Related]
24. Telomerase reverse transcriptase potentially promotes the progression of oral squamous cell carcinoma through induction of epithelial-mesenchymal transition.
Zhao T; Hu F; Qiao B; Chen Z; Tao Q
Int J Oncol; 2015 May; 46(5):2205-15. PubMed ID: 25775973
[TBL] [Abstract][Full Text] [Related]
25. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
26. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
Dawei H; Honggang D; Qian W
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
[TBL] [Abstract][Full Text] [Related]
27. Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.
Cetindis M; Biegner T; Munz A; Teriete P; Reinert S; Grimm M
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):495-503. PubMed ID: 25663193
[TBL] [Abstract][Full Text] [Related]
28. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
AbdulMajeed AA; Dalley AJ; Farah CS
Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
[TBL] [Abstract][Full Text] [Related]
29. [Expression of Twist and relation with epithelial-mesenchymal transition in oral squamous cell carcinoma].
Sun HX; Feng H; Song Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct; 33(5):534-8. PubMed ID: 26688951
[TBL] [Abstract][Full Text] [Related]
30. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.
Ko SY; Lin SC; Wong YK; Liu CJ; Chang KW; Liu TY
Cancer Lett; 2007 Jan; 245(1-2):33-43. PubMed ID: 16309826
[TBL] [Abstract][Full Text] [Related]
31. ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma.
Grimm M; Krimmel M; Polligkeit J; Alexander D; Munz A; Kluba S; Keutel C; Hoffmann J; Reinert S; Hoefert S
Eur J Cancer; 2012 Nov; 48(17):3186-97. PubMed ID: 22784549
[TBL] [Abstract][Full Text] [Related]
32. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
[TBL] [Abstract][Full Text] [Related]
33. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
Zhou J; Tao D; Xu Q; Gao Z; Tang D
Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832
[TBL] [Abstract][Full Text] [Related]
34. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M
Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
36. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
37. Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?
Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Kraut W; Reinert S
J Transl Med; 2014 Jul; 12():208. PubMed ID: 25048361
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
40. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis.
Bitu CC; Destro MF; Carrera M; da Silva SD; Graner E; Kowalski LP; Soares FA; Coletta RD
BMC Cancer; 2012 Apr; 12():146. PubMed ID: 22498108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
